{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:50:31Z","timestamp":1791352231919,"version":"4.3.1"},"reference-count":198,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R01DA064132"],"award-info":[{"award-number":["1R01DA064132"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["1R01DA064132"],"award-info":[{"award-number":["1R01DA064132"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Discov."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Worldwide implementation of antiretroviral therapy (ART) for pregnant women living with human immunodeficiency virus type-1 (HIV-1) has markedly reduced mother-to-child HIV-1 transmission rate to less than one percent. Despite this benefit, adverse pregnancy outcomes remain a major concern. Placental deficits induced by antiretroviral drugs (ARVs) are increasingly recognized as a potential causative factor. Additionally, comorbid effects of substance use on placenta cannot be overstated. Addictive substances are commonly used by people living with HIV-1 (PLWH). However, globally, nicotine exposure through smoking or tobacco use remains a major comorbidity in PLWH. Yet, to date, whether and how, HIV-1, ARVs, and nicotine together exacerbate adverse effects on placenta and affect birth outcomes is unknown. Due to ethical concerns and impracticality of obtaining placenta tissues at different stages of pregnancy, appropriate experimental models that closely recapitulate in vivo placenta physiology are essential to define how HIV-1, ART, and nicotine independently or collectively affect placental development and functions. Herein, we provide a comprehensive review of the experimental placenta models that have been or are yet to be utilized to study placental comorbid pathobiology induced by HIV-1 infection, ART, and\/or nicotine exposure. We emphasize how each model is used (or underused) to interrogate infection biology, pharmacokinetic profile, and toxico-pharmacologic mechanisms. Moreover, key limitations associated with each placenta model and necessary improvements for investigating HIV-1 and associated comorbidity are highlighted. Overall, this review seeks to educate both clinical and basic scientists on advances made, and remaining challenges in understanding comorbid effects of HIV-1-ART-nicotine on pregnancy outcomes using experimental placenta models.<\/jats:p>","DOI":"10.1038\/s41420-026-03249-x","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T18:24:21Z","timestamp":1783967061000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Placenta models for HIV-1-ART-nicotine comorbidity research: advances and remaining challenges"],"prefix":"10.1038","volume":"12","author":[{"given":"Sandip","family":"Godse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-4461","authenticated-orcid":false,"given":"Aditya N.","family":"Bade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"3249_CR1","unstructured":"The U.S. Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV 2025 [Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/whats-new."},{"key":"3249_CR2","unstructured":"The U.S. Department of Health and Human Services. Recommendations for the Use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States. 2025 [Available from: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/perinatal\/recommendations-arv-drugs-pregnancy-overview."},{"key":"3249_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/cid\/ciw791","volume":"64","author":"H Peters","year":"2017","unstructured":"Peters H, Francis K, Sconza R, Horn A, Peckham CS, Tookey PA, et al. UK mother-to-child HIV transmission rates continue to decline: 2012\u20132014. Clin Infect Dis. 2017;64:527\u20138.","journal-title":"Clin Infect Dis"},{"key":"3249_CR4","doi-asserted-by":"crossref","unstructured":"Schnoll JG, Temsamrit B, Zhang D, Song H, Ming GL, Christian KM. Evaluating neurodevelopmental consequences of perinatal exposure to antiretroviral drugs: current challenges and new approaches. J Neuroimmune Pharmacol. 2019;16:113\u201329.","DOI":"10.1007\/s11481-019-09880-z"},{"key":"3249_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/hiv.13243","volume":"23","author":"V Rasi","year":"2022","unstructured":"Rasi V, Peters H, Sconza R, Francis K, Bukasa L, Thorne C, et al. Trends in antiretroviral use in pregnancy in the UK and Ireland, 2008\u20132018. HIV Med. 2022;23:397\u2013405.","journal-title":"HIV Med"},{"key":"3249_CR6","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS). Global HIV & AIDS statistics Fact Sheet\u2014 2025 2025 [Available from: https:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"3249_CR7","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/QAD.0000000000002550","volume":"34","author":"CS Crowell","year":"2020","unstructured":"Crowell CS, Williams PL, Yildirim C, Van Dyke RB, Smith R, Chadwick EG, et al. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected. AIDS. 2020;34:1377\u201387.","journal-title":"AIDS"},{"key":"3249_CR8","doi-asserted-by":"publisher","first-page":"l4479","DOI":"10.1136\/bmj.l4479","volume":"366","author":"V Ramokolo","year":"2019","unstructured":"Ramokolo V, Goga AE, Slogrove AL, Powis KM. Unmasking the vulnerabilities of uninfected children exposed to HIV. BMJ. 2019;366:l4479.","journal-title":"BMJ"},{"key":"3249_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26159","volume":"26","author":"MA Bulterys","year":"2023","unstructured":"Bulterys MA, Njuguna I, Mahy M, Gulaid LA, Powis KM, Wedderburn CJ, et al. Neurodevelopment among children exposed to HIV and uninfected in sub-Saharan Africa. J Int AIDS Soc. 2023;26:e26159.","journal-title":"J Int AIDS Soc"},{"key":"3249_CR10","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/INF.0000000000002332","volume":"38","author":"AR Cassidy","year":"2019","unstructured":"Cassidy AR, Williams PL, Leidner J, Mayondi G, Ajibola G, Makhema J, et al. In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV-exposed Uninfected Children in Botswana. Pediatr Infect Dis J. 2019;38:828\u201334.","journal-title":"Pediatr Infect Dis J"},{"key":"3249_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03282-6","volume":"22","author":"CJ Wedderburn","year":"2024","unstructured":"Wedderburn CJ, Yeung S, Subramoney S, Fouche JP, Joshi SH, Narr KL, et al. Association of in utero HIV exposure with child brain structure and language development: a South African birth cohort study. BMC Med. 2024;22:129.","journal-title":"BMC Med"},{"key":"3249_CR12","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1097\/QAD.0000000000001211","volume":"30","author":"AT Brennan","year":"2016","unstructured":"Brennan AT, Bonawitz R, Gill CJ, Thea DM, Kleinman M, Useem J, et al. A meta-analysis assessing all-cause mortality in HIV-exposed uninfected compared with HIV-unexposed uninfected infants and children. AIDS. 2016;30:2351\u201360.","journal-title":"AIDS"},{"key":"3249_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1097\/INF.0000000000002678","volume":"39","author":"Y Ejigu","year":"2020","unstructured":"Ejigu Y, Magnus JH, Sundby J, Magnus MC. Differences in growth of HIV-exposed uninfected infants in ethiopia according to timing of in-utero antiretroviral therapy exposure. Pediatr Infect Dis J. 2020;39:730\u20136.","journal-title":"Pediatr Infect Dis J"},{"key":"3249_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/QAD.0000000000003122","volume":"36","author":"MG Fowler","year":"2022","unstructured":"Fowler MG, Aizire J, Sikorskii A, Atuhaire P, Ogwang LW, Mutebe A, et al. Growth deficits in antiretroviral and HIV-exposed uninfected versus unexposed children in Malawi and Uganda persist through 60 months of age. AIDS. 2022;36:573\u201382.","journal-title":"AIDS"},{"key":"3249_CR15","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1093\/cid\/ciy1056","volume":"68","author":"AL Slogrove","year":"2019","unstructured":"Slogrove AL, Powis KM, Cotton MF. Human immunodeficiency virus-exposed uninfected infants: surviving and thriving or overlooked by success? Clin Infect Dis. 2019;68:2156\u20138.","journal-title":"Clin Infect Dis"},{"key":"3249_CR16","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11904-019-00459-0","volume":"16","author":"CJ Wedderburn","year":"2019","unstructured":"Wedderburn CJ, Evans C, Yeung S, Gibb DM, Donald KA, Prendergast AJ. Growth and neurodevelopment of HIV-exposed uninfected children: a conceptual framework. Curr HIV\/AIDS Rep. 2019;16:501\u201313.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"3249_CR17","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.3389\/fmicb.2019.01924","volume":"10","author":"AM Weckman","year":"2019","unstructured":"Weckman AM, Ngai M, Wright J, McDonald CR, Kain KC. The impact of infection in pregnancy on placental vascular development and adverse birth outcomes. Front Microbiol. 2019;10:1924.","journal-title":"Front Microbiol"},{"key":"3249_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/uog.26111","volume":"61","author":"A Dall\u2019Asta","year":"2023","unstructured":"Dall\u2019Asta A, Melito C, Morganelli G, Lees C, Ghi T. Determinants of placental insufficiency in fetal growth restriction. Ultrasound Obstet Gynecol. 2023;61:152\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"3249_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fphys.2016.00012","volume":"7","author":"KG Dimasuay","year":"2016","unstructured":"Dimasuay KG, Boeuf P, Powell TL, Jansson T. Placental responses to changes in the maternal environment determine fetal growth. Front Physiol. 2016;7:12.","journal-title":"Front Physiol"},{"key":"3249_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ajog.2016.03.001","volume":"215","author":"JV Ilekis","year":"2016","unstructured":"Ilekis JV, Tsilou E, Fisher S, Abrahams VM, Soares MJ, Cross JC, et al. Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. Am J Obstet Gynecol. 2016;215:S1\u2013S46.","journal-title":"Am J Obstet Gynecol"},{"key":"3249_CR21","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S2055-6640(20)30247-8","volume":"4","author":"A Hill","year":"2018","unstructured":"Hill A, Clayden P, Thorne C, Christie R, Zash R. Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review. J Virus Erad. 2018;4:66\u201371.","journal-title":"J Virus Erad"},{"key":"3249_CR22","doi-asserted-by":"publisher","first-page":"e0276473","DOI":"10.1371\/journal.pone.0276473","volume":"18","author":"C Smith","year":"2023","unstructured":"Smith C, Fought AJ, Sung JF, McKinney JR, Metz TD, Fetters KB, et al. Congenital malformations and preeclampsia associated with integrase inhibitor use in pregnancy: a single-center analysis. PLoS One. 2023;18:e0276473.","journal-title":"PLoS One"},{"key":"3249_CR23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/QAD.0000000000002815","volume":"35","author":"PI Johnston","year":"2021","unstructured":"Johnston PI, Wright SW, Orr M, Pearce FA, Stevens JW, Hubbard RB, et al. Worldwide relative smoking prevalence among people living with and without HIV. AIDS. 2021;35:957\u201370.","journal-title":"AIDS"},{"key":"3249_CR24","doi-asserted-by":"publisher","first-page":"e578","DOI":"10.1016\/S2214-109X(17)30170-5","volume":"5","author":"ND Mdege","year":"2017","unstructured":"Mdege ND, Shah S, Ayo-Yusuf OA, Hakim J, Siddiqi K. Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries. Lancet Glob Health. 2017;5:e578\u2013e92.","journal-title":"Lancet Glob Health"},{"key":"3249_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/QAD.0000000000001342","volume":"31","author":"D Westreich","year":"2017","unstructured":"Westreich D, Cates J, Cohen M, Weber KM, Seidman D, Cropsey K, et al. Smoking, HIV, and risk of pregnancy loss. AIDS. 2017;31:553\u201360.","journal-title":"AIDS"},{"key":"3249_CR26","doi-asserted-by":"publisher","DOI":"10.18332\/tid\/152111","volume":"20","author":"C Delcroix-Gomez","year":"2022","unstructured":"Delcroix-Gomez C, Delcroix MH, Jamee A, Gauthier T, Marquet P, Aubard Y. Fetal growth restriction, low birth weight, and preterm birth: Effects of active or passive smoking evaluated by maternal expired CO at delivery, impacts of cessation at different trimesters. Tob Induc Dis. 2022;20:70.","journal-title":"Tob Induc Dis"},{"key":"3249_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-018-1694-4","volume":"18","author":"MC Kataoka","year":"2018","unstructured":"Kataoka MC, Carvalheira APP, Ferrari AP, Malta MB, de Barros Leite Carvalhaes MA, de Lima Parada CMG. Smoking during pregnancy and harm reduction in birth weight: a cross-sectional study. BMC Pregnancy Childbirth. 2018;18:67.","journal-title":"BMC Pregnancy Childbirth"},{"key":"3249_CR28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/ntr\/nts105","volume":"15","author":"MH Aliyu","year":"2013","unstructured":"Aliyu MH, Weldeselasse H, August EM, Keith LG, Salihu HM. Cigarette smoking and fetal morbidity outcomes in a large cohort of HIV-infected mothers. Nicotine Tob Res. 2013;15:177\u201384.","journal-title":"Nicotine Tob Res"},{"key":"3249_CR29","doi-asserted-by":"publisher","first-page":"e2355952","DOI":"10.1001\/jamanetworkopen.2023.55952","volume":"7","author":"TB Puga","year":"2024","unstructured":"Puga TB, Dai HD, Wang Y, Theye E. Maternal tobacco use during pregnancy and child neurocognitive development. JAMA Netw Open. 2024;7:e2355952.","journal-title":"JAMA Netw Open"},{"key":"3249_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-022-00981-8","volume":"20","author":"V Vachalova","year":"2022","unstructured":"Vachalova V, Karahoda R, Ottaviani M, Anandam KY, Abad C, Albrecht C, et al. Functional reorganization of monoamine transport systems during villous trophoblast differentiation: evidence of distinct differences between primary human trophoblasts and BeWo cells. Reprod Biol Endocrinol. 2022;20:112.","journal-title":"Reprod Biol Endocrinol"},{"key":"3249_CR31","doi-asserted-by":"publisher","first-page":"C1596","DOI":"10.1152\/ajpcell.1997.273.5.C1596","volume":"273","author":"F Liu","year":"1997","unstructured":"Liu F, Soares MJ, Audus KL. Permeability properties of monolayers of the human trophoblast cell line BeWo. Am J Physiol. 1997;273:C1596\u2013604.","journal-title":"Am J Physiol"},{"key":"3249_CR32","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1007\/s00204-021-03122-z","volume":"95","author":"P Alves","year":"2021","unstructured":"Alves P, Amaral C, Teixeira N, Correia-da-Silva G. Cannabidiol disrupts apoptosis, autophagy and invasion processes of placental trophoblasts. Arch Toxicol. 2021;95:3393\u2013406.","journal-title":"Arch Toxicol"},{"key":"3249_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tox.2017.04.013","volume":"385","author":"M Almada","year":"2017","unstructured":"Almada M, Costa L, Fonseca BM, Amaral C, Teixeira N, Correia-da-Silva G. The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor. Toxicology. 2017;385:67\u201373.","journal-title":"Toxicology"},{"key":"3249_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5115\/acb.20.234","volume":"54","author":"E Olivier","year":"2021","unstructured":"Olivier E, Wakx A, Fouyet S, Dutot M, Rat P. JEG-3 placental cells in toxicology studies: a promising tool to reveal pregnancy disorders. Anat Cell Biol. 2021;54:83\u201392.","journal-title":"Anat Cell Biol"},{"key":"3249_CR35","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/humupd\/dmaa017","volume":"26","author":"Y Abbas","year":"2020","unstructured":"Abbas Y, Turco MY, Burton GJ, Moffett A. Investigation of human trophoblast invasion in vitro. Hum Reprod Update. 2020;26:501\u201313.","journal-title":"Hum Reprod Update"},{"key":"3249_CR36","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejogrb.2020.02.032","volume":"247","author":"K Maduray","year":"2020","unstructured":"Maduray K, Moodley J, Mackraj I. The impact of circulating exosomes derived from early and late onset pre-eclamptic pregnancies on inflammatory cytokine secretion by BeWo cells. Eur J Obstet Gynecol Reprod Biol. 2020;247:156\u201362.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3249_CR37","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1053\/plac.1999.0494","volume":"21","author":"K Fujisawa","year":"2000","unstructured":"Fujisawa K, Nasu K, Arima K, Sugano T, Narahara H, Miyakawa I. Production of interleukin (IL)-6 and IL-8 by a choriocarcinoma cell line, BeWo. Placenta. 2000;21:354\u201360.","journal-title":"Placenta"},{"key":"3249_CR38","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.placenta.2015.08.010","volume":"36","author":"D Brunnert","year":"2015","unstructured":"Brunnert D, Piccenini S, Ehrhardt J, Zygmunt M, Goyal P. Sphingosine 1-phosphate regulates IL-8 expression and secretion via S1PR1 and S1PR2 receptors-mediated signaling in extravillous trophoblast derived HTR-8\/SVneo cells. Placenta. 2015;36:1115\u201321.","journal-title":"Placenta"},{"key":"3249_CR39","doi-asserted-by":"publisher","first-page":"15832","DOI":"10.1074\/jbc.M210470200","volume":"278","author":"G Vidricaire","year":"2003","unstructured":"Vidricaire G, Tardif MR, Tremblay MJ. The low viral production in trophoblastic cells is due to a high endocytic internalization of the human immunodeficiency virus type 1 and can be overcome by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-1. J Biol Chem. 2003;278:15832\u201341.","journal-title":"J Biol Chem"},{"key":"3249_CR40","doi-asserted-by":"publisher","first-page":"9673","DOI":"10.1128\/JVI.73.11.9673-9678.1999","volume":"73","author":"C Tscherning-Casper","year":"1999","unstructured":"Tscherning-Casper C, Papadogiannakis N, Anvret M, Stolpe L, Lindgren S, Bohlin AB, et al. The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol. 1999;73:9673\u20138.","journal-title":"J Virol"},{"key":"3249_CR41","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1365-2249.2000.01149.x","volume":"119","author":"B Mognetti","year":"2000","unstructured":"Mognetti B, Moussa M, Croitoru J, Menu E, Dormont D, Roques P, et al. HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates. Clin Exp Immunol. 2000;119:486\u201392.","journal-title":"Clin Exp Immunol"},{"key":"3249_CR42","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1089\/088922203322493021","volume":"19","author":"G Dolcini","year":"2003","unstructured":"Dolcini G, Derrien M, Chaouat G, Barre-Sinoussi F, Menu E. Cell-free HIV type 1 infection is restricted in the human trophoblast choriocarcinoma BeWo cell line, even with expression of CD4, CXCR4 and CCR5. AIDS Res Hum Retroviruses. 2003;19:857\u201364.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3249_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1089\/088922202753394673","volume":"18","author":"L Al-Harthi","year":"2002","unstructured":"Al-Harthi L, Guilbert LJ, Hoxie JA, Landay A. Trophoblasts are productively infected by CD4-independent isolate of HIV type 1. AIDS Res Hum Retroviruses. 2002;18:13\u20137.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3249_CR44","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1128\/jvi.65.4.2102-2107.1991","volume":"65","author":"V Zachar","year":"1991","unstructured":"Zachar V, Spire B, Hirsch I, Chermann JC, Ebbesen P. Human transformed trophoblast-derived cells lacking CD4 receptor exhibit restricted permissiveness for human immunodeficiency virus type 1. J Virol. 1991;65:2102\u20137.","journal-title":"J Virol"},{"key":"3249_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-31","volume":"5","author":"A Ayouba","year":"2008","unstructured":"Ayouba A, Cannou C, Nugeyre MT, Barre-Sinoussi F, Menu E. Distinct efficacy of HIV-1 entry inhibitors to prevent cell-to-cell transfer of R5 and X4 viruses across a human placental trophoblast barrier in a reconstitution model in vitro. Retrovirology. 2008;5:31.","journal-title":"Retrovirology"},{"key":"3249_CR46","doi-asserted-by":"publisher","first-page":"6359","DOI":"10.1128\/jvi.71.9.6359-6372.1997","volume":"71","author":"RT Kilani","year":"1997","unstructured":"Kilani RT, Chang LJ, Garcia-Lloret MI, Hemmings D, Winkler-Lowen B, Guilbert LJ. Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection. J Virol. 1997;71:6359\u201372.","journal-title":"J Virol"},{"key":"3249_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1089\/08892220260190317","volume":"18","author":"V Zachar","year":"2002","unstructured":"Zachar V, Fink T, Koppelhus U, Ebbesen P. Role of placental cytokines in transcriptional modulation of HIV type 1 in the isolated villous trophoblast. AIDS Res Hum Retroviruses. 2002;18:839\u201347.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3249_CR48","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1089\/aid.1992.8.1683","volume":"8","author":"DM Phillips","year":"1992","unstructured":"Phillips DM, Tan X. HIV-1 infection of the trophoblast cell line BeWo: a study of virus uptake. AIDS Res Hum Retroviruses. 1992;8:1683\u201391.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3249_CR49","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1128\/JVI.75.10.4780-4791.2001","volume":"75","author":"S Lagaye","year":"2001","unstructured":"Lagaye S, Derrien M, Menu E, Coito C, Tresoldi E, Mauclere P, et al. Cell-to-cell contact results in a selective translocation of maternal human immunodeficiency virus type 1 quasispecies across a trophoblastic barrier by both transcytosis and infection. J Virol. 2001;75:4780\u201391.","journal-title":"J Virol"},{"key":"3249_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.reprotox.2019.04.008","volume":"87","author":"T Lojpur","year":"2019","unstructured":"Lojpur T, Easton Z, Raez-Villanueva S, Laviolette S, Holloway AC, Hardy DB. Delta9-tetrahydrocannabinol leads to endoplasmic reticulum stress and mitochondrial dysfunction in human BeWo trophoblasts. Reprod Toxicol. 2019;87:21\u201331.","journal-title":"Reprod Toxicol"},{"key":"3249_CR51","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1124\/dmd.118.083329","volume":"46","author":"L Cerveny","year":"2018","unstructured":"Cerveny L, Ptackova Z, Ceckova M, Karahoda R, Karbanova S, Jiraskova L, et al. Equilibrative nucleoside transporter 1 (ENT1, SLC29A1) facilitates transfer of the antiretroviral drug abacavir across the placenta. Drug Metab Dispos. 2018;46:1817\u201326.","journal-title":"Drug Metab Dispos"},{"key":"3249_CR52","doi-asserted-by":"crossref","unstructured":"Zeng Q, Bai M, Li C, Lu S, Ma Z, Zhao Y, et al. Multiple drug transporters contribute to the placental transfer of emtricitabine. Antimicrob Agents Chemother. 2019;63:e00199\u201319.","DOI":"10.1128\/AAC.00199-19"},{"key":"3249_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110506","volume":"129","author":"L Tupova","year":"2020","unstructured":"Tupova L, Hirschmugl B, Sucha S, Pilarova V, Szekely V, Bakos E, et al. Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta. Biomed Pharmacother. 2020;129:110506.","journal-title":"Biomed Pharmacother"},{"key":"3249_CR54","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.taap.2019.02.002","volume":"368","author":"R Karahoda","year":"2019","unstructured":"Karahoda R, Ceckova M, Staud F. The inhibitory effect of antiretroviral drugs on the L-carnitine uptake in human placenta. Toxicol Appl Pharm. 2019;368:18\u201325.","journal-title":"Toxicol Appl Pharm"},{"key":"3249_CR55","doi-asserted-by":"publisher","first-page":"476.e1","DOI":"10.1016\/j.ajog.2007.02.019","volume":"196","author":"S Parry","year":"2007","unstructured":"Parry S, Zhang J. Multidrug resistance proteins affect drug transmission across the placenta. Am J Obstet Gynecol. 2007;196:476.e1\u20136.","journal-title":"Am J Obstet Gynecol"},{"key":"3249_CR56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejogrb.2010.05.023","volume":"152","author":"D Beghin","year":"2010","unstructured":"Beghin D, Forestier F, Noel-Hudson MS, Gavard L, Guibourdenche J, Farinotti R, et al. Modulation of endocrine and transport functions in human trophoblasts by saquinavir and nelfinavir. Eur J Obstet Gynecol Reprod Biol. 2010;152:55\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3249_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118291","volume":"189","author":"RS Rasna","year":"2025","unstructured":"Rasna RS, Dunk CE, Hoque MT, Bendayan R, Serghides L. Bictegravir decreases expression of system L-amino acid transporters and inhibits leucine uptake activity in a human placental cell line. Biomed Pharmacother. 2025;189:118291.","journal-title":"Biomed Pharmacother"},{"key":"3249_CR58","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S0890-6238(99)00052-0","volume":"13","author":"MA Plessinger","year":"1999","unstructured":"Plessinger MA, Miller RK. Effects of zidovudine (AZT) and dideoxyinosine (ddI) on human trophoblast cells. Reprod Toxicol. 1999;13:537\u201346.","journal-title":"Reprod Toxicol"},{"key":"3249_CR59","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0041-008X(03)00274-6","volume":"192","author":"AC Collier","year":"2003","unstructured":"Collier AC, Helliwell RJ, Keelan JA, Paxton JW, Mitchell MD, Tingle MD. 3\u2019-azido-3\u2019-deoxythymidine (AZT) induces apoptosis and alters metabolic enzyme activity in human placenta. Toxicol Appl Pharm. 2003;192:164\u201373.","journal-title":"Toxicol Appl Pharm"},{"key":"3249_CR60","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ejogrb.2024.04.035","volume":"298","author":"S Nzuza","year":"2024","unstructured":"Nzuza S, Hadebe SI, Katz AA, Matjila M. Effects of individual drug and combination antiretroviral therapy on trophoblast proliferation. Eur J Obstet Gynecol Reprod Biol. 2024;298:66\u201373.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3249_CR61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.placenta.2014.10.015","volume":"36","author":"S Komine-Aizawa","year":"2015","unstructured":"Komine-Aizawa S, Hirohata N, Aizawa S, Abiko Y, Hayakawa S. Porphyromonas gingivalis lipopolysaccharide inhibits trophoblast invasion in the presence of nicotine. Placenta. 2015;36:27\u201333.","journal-title":"Placenta"},{"key":"3249_CR62","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.reprotox.2018.07.084","volume":"81","author":"S Raez-Villanueva","year":"2018","unstructured":"Raez-Villanueva S, Ma C, Kleiboer S, Holloway AC. The effects of electronic cigarette vapor on placental trophoblast cell function. Reprod Toxicol. 2018;81:115\u201321.","journal-title":"Reprod Toxicol"},{"key":"3249_CR63","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.toxlet.2013.10.032","volume":"224","author":"JK Repo","year":"2014","unstructured":"Repo JK, Pesonen M, Mannelli C, Vahakangas K, Loikkanen J. Exposure to ethanol and nicotine induces stress responses in human placental BeWo cells. Toxicol Lett. 2014;224:264\u201371.","journal-title":"Toxicol Lett"},{"key":"3249_CR64","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.placenta.2024.01.014","volume":"147","author":"A Ye","year":"2024","unstructured":"Ye A, Li L, Chen H, Tao P, Lou S. Nicotine regulates abnormal macrophage polarization and trophoblast invasion associated with preterm labor via the alpha7nAChR\/SIRT1 axis. Placenta. 2024;147:42\u201351.","journal-title":"Placenta"},{"key":"3249_CR65","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1021\/js970455v","volume":"87","author":"S Zevin","year":"1998","unstructured":"Zevin S, Schaner ME, Giacomini KM. Nicotine transport in a human choriocarcinoma cell line (JAR). J Pharm Sci. 1998;87:702\u20136.","journal-title":"J Pharm Sci"},{"key":"3249_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2018.02.017","volume":"344","author":"J Zhou","year":"2018","unstructured":"Zhou J, Liu F, Yu L, Xu D, Li B, Zhang G, et al. nAChRs-ERK1\/2-Egr-1 signaling participates in the developmental toxicity of nicotine by epigenetically down-regulating placental 11beta-HSD2. Toxicol Appl Pharm. 2018;344:1\u201312.","journal-title":"Toxicol Appl Pharm"},{"key":"3249_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2024.108572","volume":"125","author":"IN Olomu","year":"2024","unstructured":"Olomu IN, Hoang V, Madhukar BV. Low levels of nicotine and cotinine but not benzo[a]pyrene induce human trophoblast cell proliferation. Reprod Toxicol. 2024;125:108572.","journal-title":"Reprod Toxicol"},{"key":"3249_CR68","doi-asserted-by":"crossref","unstructured":"Sheridan MA, Zhao X, Fernando RC, Gardner L, Perez-Garcia V, Li Q, et al. Characterization of primary models of human trophoblast. Development. 2021;148:dev199749.","DOI":"10.1242\/dev.199749"},{"key":"3249_CR69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2017.11.004","volume":"22","author":"H Okae","year":"2018","unstructured":"Okae H, Toh H, Sato T, Hiura H, Takahashi S, Shirane K, et al. Derivation of human trophoblast stem cells. Cell Stem Cell. 2018;22:50\u201363.e6.","journal-title":"Cell Stem Cell"},{"key":"3249_CR70","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.placenta.2025.07.090","volume":"169","author":"T Hoshiyama","year":"2025","unstructured":"Hoshiyama T, Muto M, Matsumoto S, Okamura E, Jargalsaikhan BE, Murakami T, et al. Establishment of human trophoblast stem cells from term smooth chorion. Placenta. 2025;169:114\u201322.","journal-title":"Placenta"},{"key":"3249_CR71","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1099\/0022-1317-75-6-1461","volume":"75","author":"V Zachar","year":"1994","unstructured":"Zachar V, Ebbesen P, Thomas RA, Zacharova V, Goustin AS. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication. J Gen Virol. 1994;75:1461\u20138.","journal-title":"J Gen Virol"},{"key":"3249_CR72","doi-asserted-by":"crossref","unstructured":"Yoshida K, Yano A, Kusama K, Ishikawa G, Tamura K. Alpha 1 antitrypsin regulates trophoblast syncytialization and inflammatory factor expression. Int J Mol Sci. 2022;23.","DOI":"10.3390\/ijms23041955"},{"key":"3249_CR73","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/1933719111424437","volume":"19","author":"A Vargas","year":"2012","unstructured":"Vargas A, Larocque E, Toufaily C, Rassart E, Lafond J, Barbeau B. A new luciferase-based quantitative assay for the evaluation of human trophoblast fusion. Reprod Sci. 2012;19:374\u201382.","journal-title":"Reprod Sci"},{"key":"3249_CR74","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.placenta.2005.01.012","volume":"27","author":"RL Schild","year":"2006","unstructured":"Schild RL, Sonnenberg-Hirche CM, Schaiff WT, Bildirici I, Nelson DM, Sadovsky Y. The kinase p38 regulates peroxisome proliferator activated receptor-gamma in human trophoblasts. Placenta. 2006;27:191\u20139.","journal-title":"Placenta"},{"key":"3249_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70585","volume":"97","author":"G Prates","year":"2025","unstructured":"Prates G, Li X, Folgosi V, Souza G, Teixeira S, Apoliano C, et al. Persistent Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection in the Placenta of Pregnant Women. J Med Virol. 2025;97:e70585.","journal-title":"J Med Virol"},{"key":"3249_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03898-z","volume":"12","author":"SK Morosin","year":"2021","unstructured":"Morosin SK, Delforce SJ, Corbisier de Meaultsart C, Lumbers ER, Pringle KG. FURIN and placental syncytialisation: a cautionary tale. Cell Death Dis. 2021;12:635.","journal-title":"Cell Death Dis"},{"key":"3249_CR77","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41420-023-01670-0","volume":"9","author":"X Li","year":"2023","unstructured":"Li X, Li ZH, Wang YX, Liu TH. A comprehensive review of human trophoblast fusion models: recent developments and challenges. Cell Death Discov. 2023;9:372.","journal-title":"Cell Death Discov"},{"key":"3249_CR78","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.5713\/ab.22.0415","volume":"36","author":"S Lee","year":"2023","unstructured":"Lee S, Yoo I, Cheon Y, Ka H. Spatiotemporal expression and regulation of peptidase inhibitor 3 and secretory leukocyte protease inhibitor at the maternal-fetal interface in pigs. Anim Biosci. 2023;36:1034\u201343.","journal-title":"Anim Biosci"},{"key":"3249_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1243480","volume":"14","author":"G de Souza","year":"2023","unstructured":"de Souza G, Teixeira SC, Fajardo Martinez AF, Silva RJ, Luz LC, de Lima Junior JP, et al. Trypanosoma cruzi P21 recombinant protein modulates Toxoplasma gondii infection in different experimental models of the human maternal-fetal interface. Front Immunol. 2023;14:1243480.","journal-title":"Front Immunol"},{"key":"3249_CR80","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5468\/ogs.2018.61.1.71","volume":"61","author":"GJ Cho","year":"2018","unstructured":"Cho GJ, Lee LH, Lee B, Lee J, Ahn KH, Hong SC, et al. Effects of estradiol on HIF-1alpha expression and trophoblast differentiation in first trimester villous explant cultures. Obstet Gynecol Sci. 2018;61:71\u20138.","journal-title":"Obstet Gynecol Sci"},{"key":"3249_CR81","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.reprotox.2006.01.005","volume":"22","author":"T Zdravkovic","year":"2006","unstructured":"Zdravkovic T, Genbacev O, Prakobphol A, Cvetkovic M, Schanz A, McMaster M, et al. Nicotine downregulates the l-selectin system that mediates cytotrophoblast emigration from cell columns and attachment to the uterine wall. Reprod Toxicol. 2006;22:69\u201376.","journal-title":"Reprod Toxicol"},{"key":"3249_CR82","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.plefa.2005.04.006","volume":"73","author":"JE Reseland","year":"2005","unstructured":"Reseland JE, Mundal HH, Hollung K, Haugen F, Zahid N, Anderssen SA, et al. Cigarette smoking may reduce plasma leptin concentration via catecholamines. Prostaglandins Leukot Ess Fat Acids. 2005;73:43\u20139.","journal-title":"Prostaglandins Leukot Ess Fat Acids"},{"key":"3249_CR83","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/humrep\/12.2.379","volume":"12","author":"ME Palmer","year":"1997","unstructured":"Palmer ME, Watson AL, Burton GJ. Morphological analysis of degeneration and regeneration of syncytiotrophoblast in first trimester placental villi during organ culture. Hum Reprod. 1997;12:379\u201382.","journal-title":"Hum Reprod"},{"key":"3249_CR84","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.placenta.2005.03.006","volume":"27","author":"D Baczyk","year":"2006","unstructured":"Baczyk D, Dunk C, Huppertz B, Maxwell C, Reister F, Giannoulias D, et al. Bi-potential behaviour of cytotrophoblasts in first trimester chorionic villi. Placenta. 2006;27:367\u201374.","journal-title":"Placenta"},{"key":"3249_CR85","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1007\/s00705-018-3911-x","volume":"163","author":"MR Ribeiro","year":"2018","unstructured":"Ribeiro MR, Moreli JB, Marques RE, Papa MP, Meuren LM, Rahal P, et al. Zika-virus-infected human full-term placental explants display pro-inflammatory responses and undergo apoptosis. Arch Virol. 2018;163:2687\u201399.","journal-title":"Arch Virol"},{"key":"3249_CR86","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.3389\/fimmu.2020.01899","volume":"11","author":"ZBM Rasheed","year":"2020","unstructured":"Rasheed ZBM, Lee YS, Kim SH, Rai RK, Ruano CSM, Anucha E, et al. Differential Response of Gestational Tissues to TLR3 Viral Priming Prior to Exposure to Bacterial TLR2 and TLR2\/6 Agonists. Front Immunol. 2020;11:1899.","journal-title":"Front Immunol"},{"key":"3249_CR87","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12985-025-02729-3","volume":"22","author":"KH Van der Hoek","year":"2025","unstructured":"Van der Hoek KH, Jankovic-Karasoulos T, McCullough D, Coldbeck-Shackley RC, Eyre NS, Roberts CT, et al. The first trimester human placenta responds to Zika virus infection inducing an interferon (IFN) and antiviral interferon stimulated gene (ISG) response. Virol J. 2025;22:108.","journal-title":"Virol J"},{"key":"3249_CR88","doi-asserted-by":"crossref","unstructured":"Hamilton ST, Marschall M, Rawlinson WD. Investigational antiviral therapy models for the prevention and treatment of congenital cytomegalovirus infection during pregnancy. Antimicrob Agents Chemother. 2020;65:e01627\u201320.","DOI":"10.1128\/AAC.01627-20"},{"key":"3249_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107549","volume":"26","author":"VJ Gonzalez","year":"2023","unstructured":"Gonzalez VJ, Li L, Buarpung S, Prahl M, Robinson JF, Gaw SL. Minimal mRNA uptake and inflammatory response to COVID-19 mRNA vaccine exposure in human placental explants. iScience. 2023;26:107549.","journal-title":"iScience"},{"key":"3249_CR90","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1128\/jvi.65.5.2231-2236.1991","volume":"65","author":"N Amirhessami-Aghili","year":"1991","unstructured":"Amirhessami-Aghili N, Spector SA. Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection. J Virol. 1991;65:2231\u20136.","journal-title":"J Virol"},{"key":"3249_CR91","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0143-4004(98)80044-1","volume":"19","author":"BM Polliotti","year":"1998","unstructured":"Polliotti BM, Sheikh AU, Subbarao S, Keesling SS, Lee GR, Caba J, et al. HIV-1 infection of human placental villous tissue in vitro. Placenta. 1998;19:205\u201323.","journal-title":"Placenta"},{"key":"3249_CR92","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1016\/j.celrep.2020.03.016","volume":"30","author":"Y Tang","year":"2020","unstructured":"Tang Y, Woodward BO, Pastor L, George AM, Petrechko O, Nouvet FJ, et al. Endogenous Retroviral Envelope Syncytin Induces HIV-1 Spreading and Establishes HIV Reservoirs in Placenta. Cell Rep. 2020;30:4528\u201339.e4.","journal-title":"Cell Rep"},{"key":"3249_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-3-36","volume":"3","author":"AK Kfutwah","year":"2006","unstructured":"Kfutwah AK, Mary JY, Nicola MA, Blaise-Boisseau S, Barre-Sinoussi F, Ayouba A, et al. Tumour necrosis factor-alpha stimulates HIV-1 replication in single-cycle infection of human term placental villi fragments in a time, viral dose and envelope dependent manner. Retrovirology. 2006;3:36.","journal-title":"Retrovirology"},{"key":"3249_CR94","unstructured":"Wu F, Zhang F, Ding E, Ding Y. HIV-1 infection in early human placenta in vitro: Effects of Tumor Necrosis Factor (TNF-\u03b1) and Interleukins IL-1 and IL-6. North Am J Med Sci. 2016;9:151\u201360."},{"key":"3249_CR95","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0002-9378(00)70514-X","volume":"182","author":"AU Sheikh","year":"2000","unstructured":"Sheikh AU, Polliotti BM, Miller RK. Human immunodeficiency virus infection: in situ polymerase chain reaction localization in human placentas after in utero and in vitro infection. Am J Obstet Gynecol. 2000;182:207\u201313.","journal-title":"Am J Obstet Gynecol"},{"key":"3249_CR96","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/mi.2015.87","volume":"9","author":"H El Costa","year":"2016","unstructured":"El Costa H, Quillay H, Marlin R, Cannou C, Duriez M, Benjelloun F, et al. The local environment orchestrates mucosal decidual macrophage differentiation and substantially inhibits HIV-1 replication. Mucosal Immunol. 2016;9:634\u201346.","journal-title":"Mucosal Immunol"},{"key":"3249_CR97","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1208\/s12248-020-00516-2","volume":"22","author":"D Kojovic","year":"2020","unstructured":"Kojovic D, Ghoneim RH, Serghides L, Piquette-Miller M. Role of HIV and Antiretroviral Therapy on the Expression of Placental Transporters in Women with HIV. AAPS J. 2020;22:138.","journal-title":"AAPS J"},{"key":"3249_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103771","volume":"75","author":"JC Gilmore","year":"2022","unstructured":"Gilmore JC, Hoque MT, Dai W, Mohan H, Dunk C, Serghides L, et al. Interaction between dolutegravir and folate transporters and receptor in human and rodent placenta. EBioMedicine. 2022;75:103771.","journal-title":"EBioMedicine"},{"key":"3249_CR99","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/1721727X0800600104","volume":"6","author":"M Di Stefano","year":"2008","unstructured":"Di Stefano M, Cantatore S, di Maio S, Gesualdo L, Greco P, Pastore G, et al. In vitro zidovudine-induced apoptosis demonstrated by a model of placental histoculture useful for the study of the apoptotic effects of antiretroviral drugs. Eur J Inflamm. 2008;6:25\u20139.","journal-title":"Eur J Inflamm"},{"key":"3249_CR100","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1093\/humrep\/deaa151","volume":"35","author":"S Kala","year":"2020","unstructured":"Kala S, Dunk C, Acosta S, Serghides L. Periconceptional exposure to lopinavir, but not darunavir, impairs decidualization: a potential mechanism leading to poor birth outcomes in HIV-positive pregnancies. Hum Reprod. 2020;35:1781\u201396.","journal-title":"Hum Reprod"},{"key":"3249_CR101","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2022.100081","volume":"3","author":"M Huovinen","year":"2022","unstructured":"Huovinen M, Ietta F, Repo JK, Paulesu L, Vahakangas KH. The effect of ethanol and nicotine on ER stress in human placental villous explants. Curr Res Toxicol. 2022;3:100081.","journal-title":"Curr Res Toxicol"},{"key":"3249_CR102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0890-6238(95)00006-V","volume":"9","author":"O Genbacev","year":"1995","unstructured":"Genbacev O, Bass KE, Joslin RJ, Fisher SJ. Maternal smoking inhibits early human cytotrophoblast differentiation. Reprod Toxicol. 1995;9:245\u201355.","journal-title":"Reprod Toxicol"},{"key":"3249_CR103","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0890-6238(00)00107-6","volume":"14","author":"O Genbacev","year":"2000","unstructured":"Genbacev O, McMaster MT, Lazic J, Nedeljkovic S, Cvetkovic M, Joslin R, et al. Concordant in situ and in vitro data show that maternal cigarette smoking negatively regulates placental cytotrophoblast passage through the cell cycle. Reprod Toxicol. 2000;14:495\u2013506.","journal-title":"Reprod Toxicol"},{"key":"3249_CR104","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/1874091X01004010077","volume":"4","author":"C Gallo","year":"2010","unstructured":"Gallo C, Renzi P, Loizzo S, Loizzo A, Piacente S, Festa M, et al. Potential therapeutic effects of vitamin e and C on placental oxidative stress induced by nicotine: an in vitro evidence. Open Biochem J. 2010;4:77\u201382.","journal-title":"Open Biochem J"},{"key":"3249_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2022.103737","volume":"154","author":"NA Potter","year":"2022","unstructured":"Potter NA, Arita Y, Peltier MR, Zelikoff JT. Ex vivo toxicity of E-cigarette constituents on human placental tissues. J Reprod Immunol. 2022;154:103737.","journal-title":"J Reprod Immunol"},{"key":"3249_CR106","doi-asserted-by":"publisher","first-page":"363.e1","DOI":"10.1016\/j.ajog.2007.06.025","volume":"197","author":"R Mehendale","year":"2007","unstructured":"Mehendale R, Hibbard J, Fazleabas A, Leach R. Placental angiogenesis markers sFlt-1 and PlGF: response to cigarette smoke. Am J Obstet Gynecol. 2007;197:363.e1\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"3249_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.placenta.2022.10.006","volume":"130","author":"RR Zabel","year":"2022","unstructured":"Zabel RR, Favaro RR, Groten T, Brownbill P, Jones S. Ex vivo perfusion of the human placenta to investigate pregnancy pathologies. Placenta. 2022;130:1\u20138.","journal-title":"Placenta"},{"key":"3249_CR108","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.placenta.2022.03.128","volume":"122","author":"H van Hove","year":"2022","unstructured":"van Hove H, Mathiesen L, Freriksen JJM, Vahakangas K, Colbers A, Brownbill P, et al. Placental transfer and vascular effects of pharmaceutical drugs in the human placenta ex vivo: A review. Placenta. 2022;122:29\u201345.","journal-title":"Placenta"},{"key":"3249_CR109","doi-asserted-by":"crossref","unstructured":"Grafmuller S, Manser P, Krug HF, Wick P, von Mandach U. Determination of the transport rate of xenobiotics and nanomaterials across the placenta using the ex vivo human placental perfusion model. J Vis Exp. 2013;76:50401.","DOI":"10.3791\/50401-v"},{"key":"3249_CR110","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40262-016-0457-5","volume":"56","author":"M De Sousa Mendes","year":"2017","unstructured":"De Sousa Mendes M, Lui G, Zheng Y, Pressiat C, Hirt D, Valade E, et al. A physiologically-based pharmacokinetic model to predict human fetal exposure for a drug metabolized by several CYP450 pathways. Clin Pharmacokinet. 2017;56:537\u201350.","journal-title":"Clin Pharmacokinet"},{"key":"3249_CR111","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/bcp.12815","volume":"81","author":"M De Sousa Mendes","year":"2016","unstructured":"De Sousa Mendes M, Hirt D, Vinot C, Valade E, Lui G, Pressiat C, et al. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models. Br J Clin Pharm. 2016;81:646\u201357.","journal-title":"Br J Clin Pharm"},{"key":"3249_CR112","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s40262-014-0185-7","volume":"53","author":"SA McCormack","year":"2014","unstructured":"McCormack SA, Best BM. Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals. Clin Pharmacokinet. 2014;53:989\u20131004.","journal-title":"Clin Pharmacokinet"},{"key":"3249_CR113","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/107155769400100109","volume":"1","author":"RE Bawdon","year":"1994","unstructured":"Bawdon RE, Gravell M, Hamilton R, Sever J, Miller R, Gibbs CJ. Studies on the placental transfer of cell-free human immunodeficiency virus and p24 antigen in an ex vivo human placental model. J Soc Gynecol Investig. 1994;1:45\u20138.","journal-title":"J Soc Gynecol Investig"},{"key":"3249_CR114","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/0002-9378(95)90568-5","volume":"172","author":"RE Bawdon","year":"1995","unstructured":"Bawdon RE, Gravell M, Roberts S, Hamilton R, Dax J, Sever J. Ex vivo human placental transfer of human immunodeficiency virus-1 p24 antigen. Am J Obstet Gynecol. 1995;172:530\u20132.","journal-title":"Am J Obstet Gynecol"},{"key":"3249_CR115","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jac\/dkv358","volume":"71","author":"S Schalkwijk","year":"2016","unstructured":"Schalkwijk S, Greupink R, Colbers AP, Wouterse AC, Verweij VG, van Drongelen J, et al. Placental transfer of the HIV integrase inhibitor dolutegravir in an ex vivo human cotyledon perfusion model. J Antimicrob Chemother. 2016;71:480\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"3249_CR116","doi-asserted-by":"publisher","first-page":"e0220323","DOI":"10.1371\/journal.pone.0220323","volume":"14","author":"L Mandelbrot","year":"2019","unstructured":"Mandelbrot L, Ceccaldi PF, Duro D, Pencole LeM, Peytavin L. G. Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model. PLoS One. 2019;14:e0220323.","journal-title":"PLoS One"},{"key":"3249_CR117","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1128\/AAC.00007-16","volume":"60","author":"C Vinot","year":"2016","unstructured":"Vinot C, Treluyer JM, Giraud C, Gavard L, Peytavin G, Mandelbrot L. Bidirectional transfer of raltegravir in an ex vivo human cotyledon perfusion model. Antimicrob Agents Chemother. 2016;60:3112\u20134.","journal-title":"Antimicrob Agents Chemother"},{"key":"3249_CR118","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/QAD.0000000000001681","volume":"32","author":"V Faure-Bardon","year":"2018","unstructured":"Faure-Bardon V, Mandelbrot L, Duro D, Dussaux C, Le M, Peytavin G. Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model. AIDS. 2018;32:321\u20135.","journal-title":"AIDS"},{"key":"3249_CR119","doi-asserted-by":"crossref","unstructured":"Foster EG, Gendelman HE, Bade AN. HIV-1 integrase strand transfer inhibitors and neurodevelopment. Pharmaceuticals (Basel). 2022;15:1533.","DOI":"10.3390\/ph15121533"},{"key":"3249_CR120","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1097\/QAD.0000000000002637","volume":"34","author":"L Pencole","year":"2020","unstructured":"Pencole L, Bouchet-Crivat LeMP, Duro F, Peytavin D, Mandelbrot G. L. Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model. AIDS. 2020;34:2145\u20139.","journal-title":"AIDS"},{"key":"3249_CR121","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1097\/QAD.0000000000003032","volume":"35","author":"VE Bukkems","year":"2021","unstructured":"Bukkems VE, Hidalgo-Tenorio C, Garcia C, van Hulzen AGW, Richel O, Burger DM, et al. First pharmacokinetic data of bictegravir in pregnant women living with HIV. AIDS. 2021;35:2405\u20136.","journal-title":"AIDS"},{"key":"3249_CR122","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1016\/S0140-6736(22)00538-4","volume":"399","author":"S Delany-Moretlwe","year":"2022","unstructured":"Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, et al. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial. Lancet. 2022;399:1779\u201389.","journal-title":"Lancet"},{"key":"3249_CR123","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000028231","volume":"57","author":"BV Sastry","year":"1998","unstructured":"Sastry BV, Chance MB, Hemontolor ME, Goddijn-Wessel TA. Formation and retention of cotinine during placental transfer of nicotine in human placental cotyledon. Pharmacology. 1998;57:104\u201316.","journal-title":"Pharmacology"},{"key":"3249_CR124","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000028270","volume":"58","author":"BV Rama Sastry","year":"1999","unstructured":"Rama Sastry BV, Hemontolor ME, Olenick M. Prostaglandin E2 in human placenta: its vascular effects and activation of prostaglandin E2 formation by nicotine and cotinine. Pharmacology. 1999;58:70\u201386.","journal-title":"Pharmacology"},{"key":"3249_CR125","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1016\/S0024-3205(98)00522-0","volume":"63","author":"A Pastrakuljic","year":"1998","unstructured":"Pastrakuljic A, Schwartz R, Simone C, Derewlany LO, Knie B, Koren G. Transplacental transfer and biotransformation studies of nicotine in the human placental cotyledon perfused in vitro. Life Sci. 1998;63:2333\u201342.","journal-title":"Life Sci"},{"key":"3249_CR126","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0022-3565(24)39049-4","volume":"294","author":"A Pastrakuljic","year":"2000","unstructured":"Pastrakuljic A, Derewlany LO, Knie B, Koren G. The effects of cocaine and nicotine on amino acid transport across the human placental cotyledon perfused in vitro. J Pharm Exp Ther. 2000;294:141\u20136.","journal-title":"J Pharm Exp Ther"},{"key":"3249_CR127","doi-asserted-by":"publisher","first-page":"E443","DOI":"10.1152\/ajpendo.00478.2013","volume":"306","author":"AC Holloway","year":"2014","unstructured":"Holloway AC, Salomon A, Soares MJ, Garnier V, Raha S, Sergent F, et al. Characterization of the adverse effects of nicotine on placental development: in vivo and in vitro studies. Am J Physiol Endocrinol Metab. 2014;306:E443\u201356.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"3249_CR128","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.coviro.2016.06.010","volume":"19","author":"J Victor Garcia","year":"2016","unstructured":"Victor Garcia J. Humanized mice for HIV and AIDS research. Curr Opin Virol. 2016;19:56\u201364.","journal-title":"Curr Opin Virol"},{"key":"3249_CR129","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1128\/AAC.00747-10","volume":"54","author":"MA Winters","year":"2010","unstructured":"Winters MA, Van Rompay KK, Kashuba AD, Shulman NS, Holodniy M. Maternal-fetal pharmacokinetics and dynamics of a single intrapartum dose of maraviroc in rhesus macaques. Antimicrob Agents Chemother. 2010;54:4059\u201363.","journal-title":"Antimicrob Agents Chemother"},{"key":"3249_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/srep23513","volume":"6","author":"M Arainga","year":"2016","unstructured":"Arainga M, Su H, Poluektova LY, Gorantla S, Gendelman HE. HIV-1 cellular and tissue replication patterns in infected humanized mice. Sci Rep. 2016;6:23513.","journal-title":"Sci Rep"},{"key":"3249_CR131","doi-asserted-by":"publisher","first-page":"370.e1","DOI":"10.1016\/j.ajog.2014.12.042","volume":"212","author":"JO Lo","year":"2015","unstructured":"Lo JO, Schabel MC, Roberts VH, Morgan TK, Rasanen JP, Kroenke CD, et al. Vitamin C supplementation ameliorates the adverse effects of nicotine on placental hemodynamics and histology in nonhuman primates. Am J Obstet Gynecol. 2015;212:370.e1\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"3249_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105943","volume":"120","author":"M Ranjbar","year":"2025","unstructured":"Ranjbar M, Hsieh I, Collomb M, Serghides L. A mouse model of HIV in pregnancy: the EcoHIV+ pregnancy model. EBioMedicine. 2025;120:105943.","journal-title":"EBioMedicine"},{"key":"3249_CR133","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1600-0684.1991.tb00516.x","volume":"20","author":"HM McClure","year":"1991","unstructured":"McClure HM, Anderson DC, Fultz PN, Ansari AA, Jehuda-Cohen T, Villinger F, et al. Maternal transmission of SIVsmm in rhesus macaques. J Med Primatol. 1991;20:182\u20137.","journal-title":"J Med Primatol"},{"key":"3249_CR134","doi-asserted-by":"publisher","first-page":"7982","DOI":"10.1128\/jvi.69.12.7982-7990.1995","volume":"69","author":"AM Amedee","year":"1995","unstructured":"Amedee AM, Lacour N, Gierman JL, Martin LN, Clements JE, Bohm R Jr, et al. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol. 1995;69:7982\u201390.","journal-title":"J Virol"},{"key":"3249_CR135","doi-asserted-by":"publisher","first-page":"300ra125","DOI":"10.1126\/scitranslmed.aac5547","volume":"7","author":"CA Baker","year":"2015","unstructured":"Baker CA, Swainson L, Lin DL, Wong S, Hartigan-O\u2019Connor DJ, Lifson JD, et al. Exposure to SIV in utero results in reduced viral loads and altered responsiveness to postnatal challenge. Sci Transl Med. 2015;7:300ra125.","journal-title":"Sci Transl Med"},{"key":"3249_CR136","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1600-0684.1991.tb00518.x","volume":"20","author":"HD Ochs","year":"1991","unstructured":"Ochs HD, Morton WR, Tsai CC, Thouless ME, Zhu Q, Kuller LD, et al. Maternal-fetal transmission of SIV in macaques: disseminated adenovirus infection in an offspring with congenital SIV infection. J Med Primatol. 1991;20:193\u2013200.","journal-title":"J Med Primatol"},{"key":"3249_CR137","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1600-0684.1996.tb00020.x","volume":"25","author":"A Martin Amedee","year":"1996","unstructured":"Martin Amedee A, Lacour N, Martin LN, Clements JE, Bohm RB Jr, Davison B, et al. Genotypic analysis of infant macaques infected transplacentally and orally. J Med Primatol. 1996;25:225\u201335.","journal-title":"J Med Primatol"},{"key":"3249_CR138","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1600-0684.1990.tb00443.x","volume":"19","author":"B Davison-Fairburn","year":"1990","unstructured":"Davison-Fairburn B, Blanchard J, Hu FS, Martin L, Harrison R, Ratterree M, et al. Experimental infection of timed-pregnant rhesus monkeys with simian immunodeficiency virus (SIV) during early, middle, and late gestation. J Med Primatol. 1990;19:381\u201393.","journal-title":"J Med Primatol"},{"key":"3249_CR139","doi-asserted-by":"crossref","unstructured":"Zhang C, Zaman LA, Poluektova LY, Gorantla S, Gendelman HE, Dash PK. Humanized mice for studies of HIV-1 persistence and elimination. Pathogens. 2023;12:879.","DOI":"10.3390\/pathogens12070879"},{"key":"3249_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02885-x","volume":"9","author":"B Sillman","year":"2018","unstructured":"Sillman B, Bade AN, Dash PK, Bhargavan B, Kocher T, Mathews S, et al. Creation of a long-acting nanoformulated dolutegravir. Nat Commun. 2018;9:443.","journal-title":"Nat Commun"},{"key":"3249_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10366-y","volume":"10","author":"PK Dash","year":"2019","unstructured":"Dash PK, Kaminski R, Bella R, Su H, Mathews S, Ahooyi TM, et al. Sequential LASER ART and CRISPR Treatments Eliminate HIV-1 in a Subset of Infected Humanized Mice. Nat Commun. 2019;10:2753.","journal-title":"Nat Commun"},{"key":"3249_CR142","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1203\/00006450-199501000-00012","volume":"37","author":"RR Franks","year":"1995","unstructured":"Franks RR, Ray PE, Babbott CC, Bryant JL, Notkins AL, Santoro TJ, et al. Maternal-fetal interactions affect growth of human immunodeficiency virus type 1 transgenic mice. Pediatr Res. 1995;37:56\u201363.","journal-title":"Pediatr Res"},{"key":"3249_CR143","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00042560-200203010-00001","volume":"29","author":"AF Tarantal","year":"2002","unstructured":"Tarantal AF, Castillo A, Ekert JE, Bischofberger N, Martin RB. Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). J Acquir Immune Defic Syndr. 2002;29:207\u201320.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3249_CR144","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-3565(24)37386-0","volume":"285","author":"T Tuntland","year":"1998","unstructured":"Tuntland T, Odinecs A, Nosbisch C, Unadkat JD. In vivo maternal-fetal-amniotic fluid pharmacokinetics of zidovudine in the pigtailed macaque: comparison of steady-state and single-dose regimens. J Pharm Exp Ther. 1998;285:54\u201362.","journal-title":"J Pharm Exp Ther"},{"key":"3249_CR145","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S0002-9378(96)70313-7","volume":"174","author":"T Tuntland","year":"1996","unstructured":"Tuntland T, Nosbisch C, Baughman WL, Massarella J, Unadkat JD. Mechanism and rate of placental transfer of zalcitabine (2\u2019,3\u2019-dideoxycytidine) in Macaca nemestrina. Am J Obstet Gynecol. 1996;174:856\u201363.","journal-title":"Am J Obstet Gynecol"},{"key":"3249_CR146","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1128\/AAC.40.1.196","volume":"40","author":"A Odinecs","year":"1996","unstructured":"Odinecs A, Nosbisch C, Keller RD, Baughman WL, Unadkat JD. In vivo maternal-fetal pharmacokinetics of stavudine (2\u2019,3\u2019-didehydro-3\u2019-deoxythymidine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother. 1996;40:196\u2013202.","journal-title":"Antimicrob Agents Chemother"},{"key":"3249_CR147","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1128\/AAC.39.2.343","volume":"39","author":"CM Pereira","year":"1995","unstructured":"Pereira CM, Nosbisch C, Baughman WL, Unadkat JD. Effect of zidovudine on transplacental pharmacokinetics of ddI in the pigtailed macaque (Macaca nemestrina). Antimicrob Agents Chemother. 1995;39:343\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"3249_CR148","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/00126334-200204010-00001","volume":"29","author":"OA Olivero","year":"2002","unstructured":"Olivero OA, Fernandez JJ, Antiochos BB, Wagner JL, St Claire ME, Poirier MC. Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys. J Acquir Immune Defic Syndr. 2002;29:323\u20139.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3249_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.116170","volume":"450","author":"JM Minoia","year":"2022","unstructured":"Minoia JM, Filia MF, Roma MI, De Fino FT, Copello GJ, Peroni RN. Selective modulation of placental and fetal MDR transporters by chronic in utero exposure to NRTIs in Sprague-Dawley rats: Importance for fetoprotection. Toxicol Appl Pharm. 2022;450:116170.","journal-title":"Toxicol Appl Pharm"},{"key":"3249_CR150","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.taap.2017.07.005","volume":"330","author":"MF Filia","year":"2017","unstructured":"Filia MF, Marchini T, Minoia JM, Roma MI, De Fino FT, Rubio MC, et al. Induction of ABCG2\/BCRP restricts the distribution of zidovudine to the fetal brain in rats. Toxicol Appl Pharm. 2017;330:74\u201383.","journal-title":"Toxicol Appl Pharm"},{"key":"3249_CR151","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/0002-9378(89)90391-8","volume":"161","author":"BB Little","year":"1989","unstructured":"Little BB, Bawdon RE, Christmas JT, Sobhi S, Gilstrap LC. 3rd. Pharmacokinetics of azidothymidine during late pregnancy in Long-Evans rats. Am J Obstet Gynecol. 1989;161:732\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"3249_CR152","doi-asserted-by":"publisher","first-page":"e0242513","DOI":"10.1371\/journal.pone.0242513","volume":"15","author":"A Sarkar","year":"2020","unstructured":"Sarkar A, Balogun K, Guzman Lenis MS, Acosta S, Mount HT, Serghides L. In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice. PLoS One. 2020;15:e0242513.","journal-title":"PLoS One"},{"key":"3249_CR153","doi-asserted-by":"crossref","unstructured":"Balogun K, Serghides L. Comparison of the effects of three dual-nucleos(t)ide reverse transcriptase inhibitor backbones on placenta mitochondria toxicity and oxidative stress using a mouse pregnancy model. pharmaceutics. 2022;14:1063.","DOI":"10.3390\/pharmaceutics14051063"},{"key":"3249_CR154","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1007\/s12035-021-02508-5","volume":"58","author":"AN Bade","year":"2021","unstructured":"Bade AN, McMillan JM, Liu Y, Edagwa BJ, Gendelman HE. Dolutegravir inhibition of matrix metalloproteinases affects mouse neurodevelopment. Mol Neurobiol. 2021;58:5703\u201321.","journal-title":"Mol Neurobiol"},{"key":"3249_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1681094","volume":"16","author":"M Summerlin","year":"2025","unstructured":"Summerlin M, Uberti MG, Shinde D, Foster EG, Sillman B, Kumar M, et al. CEST MRI detects antiretroviral drug toxicities in the developing mouse brain. Front Pharm. 2025;16:1681094.","journal-title":"Front Pharm"},{"key":"3249_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1294579","volume":"14","author":"EG Foster","year":"2023","unstructured":"Foster EG, Sillman B, Liu Y, Summerlin M, Kumar V, Sajja BR, et al. Long-acting dolutegravir formulations prevent neurodevelopmental impairments in a mouse model. Front Pharm. 2023;14:1294579.","journal-title":"Front Pharm"},{"key":"3249_CR157","doi-asserted-by":"crossref","unstructured":"Beck L, Kirkham MN, Shin M, Bikman BT, Reynolds PR, Arroyo JA. Impact of secondhand smoke and E-cigarette exposure on placental apoptotic and growth-regulatory proteins in mouse pregnancy. Cells. 2025;14:453.","DOI":"10.3390\/cells14060453"},{"key":"3249_CR158","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2022.153272","volume":"477","author":"KM Cahill","year":"2022","unstructured":"Cahill KM, Johnson TK, Perveen Z, Schexnayder M, Xiao R, Heffernan LM, et al. In utero exposures to mint-flavored JUUL aerosol impair lung development and aggravate house dust mite-induced asthma in adult offspring mice. Toxicology. 2022;477:153272.","journal-title":"Toxicology"},{"key":"3249_CR159","doi-asserted-by":"crossref","unstructured":"Olverson ZA, Saldana SJ, Miller RA, Gorr MW. E-cigarette exposure during pregnancy impairs uterine artery blood flow and feto-placental function. Toxicol Sci. 2026;209:kfaf161.","DOI":"10.1093\/toxsci\/kfaf161"},{"key":"3249_CR160","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s43856-025-01094-0","volume":"5","author":"MW Marbrey","year":"2025","unstructured":"Marbrey MW, Cripps SM, Huang R, Kistner BM, Somany A, Douglas ES, et al. Flavored e-cigarettes modulate embryo development, fetal growth, and potentiate early fetal demise without nicotine. Commun Med (Lond). 2025;5:373.","journal-title":"Commun Med (Lond)"},{"key":"3249_CR161","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1007\/s12012-025-10022-6","volume":"25","author":"JA Griffith","year":"2025","unstructured":"Griffith JA, Schafner KJ, Garner KL, DeVallance E, Lewis SE, Nurkiewicz TR, et al. Maternal electronic cigarette inhalation exposure during gestation: impacts on prolactin and xanthine oxidase. Cardiovasc Toxicol. 2025;25:1095\u2013106.","journal-title":"Cardiovasc Toxicol"},{"key":"3249_CR162","doi-asserted-by":"publisher","first-page":"e0122295","DOI":"10.1371\/journal.pone.0122295","volume":"10","author":"MK Wong","year":"2015","unstructured":"Wong MK, Nicholson CJ, Holloway AC, Hardy DB. Maternal nicotine exposure leads to impaired disulfide bond formation and augmented endoplasmic reticulum stress in the rat placenta. PLoS One. 2015;10:e0122295.","journal-title":"PLoS One"},{"key":"3249_CR163","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.toxlet.2018.07.022","volume":"296","author":"G Zhang","year":"2018","unstructured":"Zhang G, Zhou J, Huang W, Yu L, Zhang Y, Wang H. Placental mechanism of prenatal nicotine exposure-reduced blood cholesterol levels in female fetal rats. Toxicol Lett. 2018;296:31\u20138.","journal-title":"Toxicol Lett"},{"key":"3249_CR164","doi-asserted-by":"crossref","unstructured":"Schank M, Zhao J, Moorman JP, Yao ZQ. The impact of HIV- and ART-induced mitochondrial dysfunction in cellular senescence and aging. Cells. 2021;10:174.","DOI":"10.3390\/cells10010174"},{"key":"3249_CR165","first-page":"5","volume":"45","author":"TD Popoola","year":"2016","unstructured":"Popoola TD, Awodele O. Interplay between antiretroviral therapy and oxidative stress in HIV seropositive patients. Afr J Med Med Sci. 2016;45:5\u201321.","journal-title":"Afr J Med Med Sci"},{"key":"3249_CR166","doi-asserted-by":"publisher","first-page":"8852","DOI":"10.3390\/cimb46080523","volume":"46","author":"R Harshithkumar","year":"2024","unstructured":"Harshithkumar R, Shah P, Jadaun P, Mukherjee A. ROS chronicles in HIV infection: genesis of oxidative stress, associated pathologies, and therapeutic strategies. Curr Issues Mol Biol. 2024;46:8852\u201373.","journal-title":"Curr Issues Mol Biol"},{"key":"3249_CR167","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s13365-020-00861-0","volume":"26","author":"S Andhavarapu","year":"2020","unstructured":"Andhavarapu S, Katuri A, Bryant J, Patel V, Gupta U, Asemu G, et al. Intersecting roles of ER stress, mitochondrial dysfunction, autophagy, and calcium homeostasis in HIV-associated neurocognitive disorder. J Neurovirol. 2020;26:664\u201375.","journal-title":"J Neurovirol"},{"key":"3249_CR168","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41586-018-0753-3","volume":"564","author":"MY Turco","year":"2018","unstructured":"Turco MY, Gardner L, Kay RG, Hamilton RS, Prater M, Hollinshead MS, et al. Trophoblast organoids as a model for maternal-fetal interactions during human placentation. Nature. 2018;564:263\u20137.","journal-title":"Nature"},{"key":"3249_CR169","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.stemcr.2018.07.004","volume":"11","author":"S Haider","year":"2018","unstructured":"Haider S, Meinhardt G, Saleh L, Kunihs V, Gamperl M, Kaindl U, et al. Self-Renewing Trophoblast Organoids Recapitulate the Developmental Program of the Early Human Placenta. Stem Cell Rep. 2018;11:537\u201351.","journal-title":"Stem Cell Rep"},{"key":"3249_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112099","volume":"28","author":"J Zhou","year":"2025","unstructured":"Zhou J, Sheridan MA, Tian Y, Dahlgren KJ, Messler M, Peng T, et al. Development of apical out trophoblast stem cell derived organoids to model early human pregnancy. iScience. 2025;28:112099.","journal-title":"iScience"},{"key":"3249_CR171","doi-asserted-by":"crossref","unstructured":"Yang L, Semmes EC, Ovies C, Megli C, Permar S, Gilner JB, et al. Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface. Elife. 2022;11:e79794.","DOI":"10.7554\/eLife.79794"},{"key":"3249_CR172","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.placenta.2026.01.018","volume":"175","author":"G Meinhardt","year":"2026","unstructured":"Meinhardt G, Waldhausl H, Saleh L, Haider S, Pollheimer J, Fiala C, et al. Characterization, organoid formation and differentiation potential of the novel term trophoblast cell line TB\/SVTERT350. Placenta. 2026;175:73\u20137.","journal-title":"Placenta"},{"key":"3249_CR173","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.stem.2022.04.004","volume":"29","author":"RM Karvas","year":"2022","unstructured":"Karvas RM, Khan SA, Verma S, Yin Y, Kulkarni D, Dong C, et al. Stem-cell-derived trophoblast organoids model human placental development and susceptibility to emerging pathogens. Cell Stem Cell. 2022;29:810\u201325 e8.","journal-title":"Cell Stem Cell"},{"key":"3249_CR174","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.placenta.2024.08.014","volume":"166","author":"A Hawkins","year":"2025","unstructured":"Hawkins A, Pantazi P, Yang L, Coyne CB, Bokun V, Lemme-Dumit JM, et al. Long-term culture and passaging of term trophoblast for the investigation of syncytiotrophoblast function. Placenta. 2025;166:25\u201332.","journal-title":"Placenta"},{"key":"3249_CR175","first-page":"V174","volume":"75","author":"JH Bauer","year":"1987","unstructured":"Bauer JH, Reams GP. The role of calcium entry blockers in hypertensive emergencies. Circulation. 1987;75:V174\u201380.","journal-title":"Circulation"},{"key":"3249_CR176","doi-asserted-by":"publisher","first-page":"3441","DOI":"10.1038\/s41596-020-0381-x","volume":"15","author":"MA Sheridan","year":"2020","unstructured":"Sheridan MA, Fernando RC, Gardner L, Hollinshead MS, Burton GJ, Moffett A, et al. Establishment and differentiation of long-term trophoblast organoid cultures from the human placenta. Nat Protoc. 2020;15:3441\u201363.","journal-title":"Nat Protoc"},{"key":"3249_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41158-0","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Huang XY, Sun MX, Wang Y, Zhou HY, Tian Y, et al. Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids. Nat Commun. 2023;14:5541.","journal-title":"Nat Commun"},{"key":"3249_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100849","volume":"3","author":"D Ruan","year":"2022","unstructured":"Ruan D, Ye ZW, Yuan S, Li Z, Zhang W, Ong CP, et al. Human early syncytiotrophoblasts are highly susceptible to SARS-CoV-2 infection. Cell Rep Med. 2022;3:100849.","journal-title":"Cell Rep Med"},{"key":"3249_CR179","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61138-w","volume":"16","author":"CJ Megli","year":"2025","unstructured":"Megli CJ, Zack RK, McGaughey JJ, Hoehl RM, Snisky T, Hartman AL, et al. Oropouche virus infects human trophoblasts and placenta explants. Nat Commun. 2025;16:6040.","journal-title":"Nat Commun"},{"key":"3249_CR180","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2024.117112","volume":"492","author":"S Huang","year":"2024","unstructured":"Huang S, Yao B, Guo Y, Zhang Y, Li H, Zhang Y, et al. Human trophoblast organoids for improved prediction of placental ABC transporter-mediated drug transport. Toxicol Appl Pharm. 2024;492:117112.","journal-title":"Toxicol Appl Pharm"},{"key":"3249_CR181","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45279-y","volume":"15","author":"T Hori","year":"2024","unstructured":"Hori T, Okae H, Shibata S, Kobayashi N, Kobayashi EH, Oike A, et al. Trophoblast stem cell-based organoid models of the human placental barrier. Nat Commun. 2024;15:962.","journal-title":"Nat Commun"},{"key":"3249_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116825","volume":"45","author":"LF Cabo","year":"2026","unstructured":"Cabo LF, Yang L, Gao M, da Silva RJ, Washington NN, Reilly SM, et al. Toxoplasma gondii infection misdirects placental trophoblast lineage specification. Cell Rep. 2026;45:116825.","journal-title":"Cell Rep"},{"key":"3249_CR183","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/HYPERTENSIONAHA.125.25342","volume":"82","author":"S Huang","year":"2025","unstructured":"Huang S, Zhang Y, Guo Y, Zhang Y, Huang J, Yang Y, et al. Constructing a preeclampsia organoid model to elucidate the mechanism of aspirin. Hypertension. 2025;82:e171\u2013e85.","journal-title":"Hypertension"},{"key":"3249_CR184","doi-asserted-by":"publisher","first-page":"20263","DOI":"10.1021\/acs.est.5c07230","volume":"59","author":"M Li","year":"2025","unstructured":"Li M, Xu C, Li L, Gao F, Xu C, Yu Y, et al. Placentation disruption by perfluorooctanoic acid and perfluorooctanesulfonate in human trophoblast organoids. Environ Sci Technol. 2025;59:20263\u201375.","journal-title":"Environ Sci Technol"},{"key":"3249_CR185","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1109\/TBME.2020.3038466","volume":"68","author":"AJ Deloria","year":"2021","unstructured":"Deloria AJ, Haider S, Dietrich B, Kunihs V, Oberhofer S, Knofler M, et al. Ultra-high-resolution 3D optical coherence tomography reveals inner structures of human placenta-derived trophoblast organoids. IEEE Trans Biomed Eng. 2021;68:2368\u201376.","journal-title":"IEEE Trans Biomed Eng"},{"key":"3249_CR186","doi-asserted-by":"crossref","unstructured":"Yang L, Liang P, Yang H, Coyne CB. Trophoblast organoids with physiological polarity model placental structure and function. J Cell Sci. 2024;137:jcs261528.","DOI":"10.1242\/jcs.261528"},{"key":"3249_CR187","doi-asserted-by":"crossref","unstructured":"Thalheim T, Siebert S, Quaas M, Herberg M, Schweiger MR, Aust G, et al. Epigenetic drifts during long-term intestinal organoid culture. Cells. 2021;10:1718.","DOI":"10.3390\/cells10071718"},{"key":"3249_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-29424-1","volume":"15","author":"S Liu","year":"2025","unstructured":"Liu S, Peng H, Meng J, Zhuo L, Fu S, Yang W. Cell passage number drives transcriptomic drift as an overlooked factor in experimental reproducibility. Sci Rep. 2025;15:44984.","journal-title":"Sci Rep"},{"key":"3249_CR189","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s42003-021-02116-y","volume":"4","author":"J Franzen","year":"2021","unstructured":"Franzen J, Georgomanolis T, Selich A, Kuo CC, Stoger R, Brant L, et al. DNA methylation changes during long-term in vitro cell culture are caused by epigenetic drift. Commun Biol. 2021;4:598.","journal-title":"Commun Biol"},{"key":"3249_CR190","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.devcel.2024.01.023","volume":"59","author":"MJ Shannon","year":"2024","unstructured":"Shannon MJ, McNeill GL, Koksal B, Baltayeva J, Wachter J, Castellana B, et al. Single-cell assessment of primary and stem cell-derived human trophoblast organoids as placenta-modeling platforms. Dev Cell. 2024;59:776\u201392.e11.","journal-title":"Dev Cell"},{"key":"3249_CR191","doi-asserted-by":"crossref","unstructured":"Keenen MM, Yang L, Liang H, Farmer VJ, Worota RE, Singh R, et al. Comparative analysis of the syncytiotrophoblast in placenta tissue and trophoblast organoids using snRNA sequencing. Elife. 2025;13:RP101170.","DOI":"10.7554\/eLife.101170.3"},{"key":"3249_CR192","doi-asserted-by":"crossref","unstructured":"Elzinga FA, Khalili B, Touw DJ, Prins JR, Olinga P, Leuvenink HGD, et al. Placenta-on-a-Chip as an In Vitro Approach to Evaluate the Physiological and Structural Characteristics of the Human Placental Barrier upon Drug Exposure: A Systematic Review. J Clin Med. 2023;12:4315.","DOI":"10.3390\/jcm12134315"},{"key":"3249_CR193","doi-asserted-by":"publisher","DOI":"10.1002\/gch2.201800112","volume":"3","author":"RL Pemathilaka","year":"2019","unstructured":"Pemathilaka RL, Caplin JD, Aykar SS, Montazami R, Hashemi NN. Placenta-on-a-chip: in vitro study of caffeine transport across placental barrier using liquid chromatography mass spectrometry. Glob Chall. 2019;3:1800112.","journal-title":"Glob Chall"},{"key":"3249_CR194","doi-asserted-by":"publisher","unstructured":"Blundell C, Yi YS, Ma L, Tess ER, Farrell MJ, Georgescu A, et al. Placental drug transport-on-a-chip: a microengineered in vitro model of transporter-mediated drug efflux in the human placental barrier. Adv Healthc Mater. 2018;7(2). https:\/\/doi.org\/10.1002\/adhm.201700786.","DOI":"10.1002\/adhm.201700786"},{"key":"3249_CR195","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tiv.2018.08.014","volume":"54","author":"F Yin","year":"2019","unstructured":"Yin F, Zhu Y, Zhang M, Yu H, Chen W, Qin J. A 3D human placenta-on-a-chip model to probe nanoparticle exposure at the placental barrier. Toxicol Vitr. 2019;54:105\u201313.","journal-title":"Toxicol Vitr"},{"key":"3249_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2024.117051","volume":"285","author":"R Cao","year":"2024","unstructured":"Cao R, Guo Y, Liu J, Guo Y, Li X, Xie F, et al. Assessment of nanotoxicity in a human placenta-on-a-chip from trophoblast stem cells. Ecotoxicol Environ Saf. 2024;285:117051.","journal-title":"Ecotoxicol Environ Saf"},{"key":"3249_CR197","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00018-022-04648-w","volume":"80","author":"SM Ghorbanpour","year":"2023","unstructured":"Ghorbanpour SM, Richards C, Pienaar D, Sesperez K, Aboulkheyr EsH, Nikolic VN, et al. A placenta-on-a-chip model to determine the regulation of FKBPL and galectin-3 in preeclampsia. Cell Mol Life Sci. 2023;80:44.","journal-title":"Cell Mol Life Sci"},{"key":"3249_CR198","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1021\/acsbiomaterials.8b00653","volume":"4","author":"Y Zhu","year":"2018","unstructured":"Zhu Y, Yin F, Wang H, Wang L, Yuan J, Qin J. Placental barrier-on-a-chip: modeling placental inflammatory responses to bacterial infection. ACS Biomater Sci Eng. 2018;4:3356\u201363.","journal-title":"ACS Biomater Sci Eng"}],"container-title":["Cell Death Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03249-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03249-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03249-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:02:04Z","timestamp":1791349324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41420-026-03249-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":198,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3249"],"URL":"https:\/\/doi.org\/10.1038\/s41420-026-03249-x","relation":{},"ISSN":["2058-7716"],"issn-type":[{"value":"2058-7716","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"406"}}